Krishna (@krishna___s) 's Twitter Profile
Krishna

@krishna___s

NW London Gastroenterology Registrar - IBD Clinical Research Fellow

ID: 1231603713120309251

calendar_today23-02-2020 15:36:31

40 Tweet

88 Followers

138 Following

Krishna (@krishna___s) 's Twitter Profile Photo

Just had the most eye-opening and humbling call with an anaesthetic resident who works within the private + public healthcare system in Nairobi,Kenya. Despite our challenges in the NHS, we are extremely privileged to work in a resource rich healthcare system that does not 1/2

Krishna (@krishna___s) 's Twitter Profile Photo

1/2 charge its patients £30/hour for Oxygen or £3000 for a dose of Tociluzimab. NIV is not used for risk of AGP. How can we help the developing world? This is very much a global pandemic and for us to come out the other end, our neighbouring countries and continents need to also

GLINT Research Group (@glint_research) 's Twitter Profile Photo

GLINT Research Group ‘s first Educational Evening with DR FALK “So you want to do a MD/PHD” is only a few days away! See all of you lucky attendees at 6p.m. on 25th May 2023, for some exciting talks with Ben Mullish Misha Kabir and others!

GLINT Research Group (@glint_research) 's Twitter Profile Photo

Excitingly GLINT Research Group ‘s second in-person Educational Evening with DR FALK “Maximising your Gastroenterology Registrar Training” is taking place 6p.m. on 30th May 2024, and is now OPEN for registration via this link-> eventbrite.com/e/glintxfalk-e… Spaces are limited so SIGN-UP!

BSG (@britsocgastro) 's Twitter Profile Photo

Our latest podcast is available! Catch up on the discussion about the Advanced Therapies in Ulcerative Colitis section of the new BSG guidelines. #UC #IBD #Colitis #Podcasts bsg.org.uk/bsg-podcasts

Our latest podcast is available! Catch up on the discussion about the Advanced Therapies in Ulcerative Colitis section of the new BSG guidelines.

#UC #IBD #Colitis #Podcasts 

bsg.org.uk/bsg-podcasts
Frontline Gastro (@frontgastro_bmj) 's Twitter Profile Photo

⚠️ ❗ Real-world effectiveness of risankizumab in Crohn’s disease: a pan UK retrospective cohort study 🚨 🚨 👫 763 participants with CD 💉 Treatment persistence at 6 and 12 months was 95.4% and 89.2%, respectively ✅ Rates of clinical, CRP and FCAL remission were 52%

⚠️ ❗  Real-world effectiveness of risankizumab in Crohn’s disease: a pan UK retrospective cohort study 🚨 🚨 

👫 763 participants with CD
 💉 Treatment persistence at 6 and 12 months was 95.4% and 89.2%, respectively
✅ Rates of clinical, CRP and FCAL remission were 52%